User menu

Selective cancer-germline gene expression in pediatric brain tumors

Bibliographic reference Jacobs, Joannes F. M. ; Grauer, Oliver M. ; Brasseur, Francis ; Hoogerbrugge, Peter M. ; Wesseling, Pieter ; et. al. Selective cancer-germline gene expression in pediatric brain tumors. In: Journal of Neuro-Oncology, Vol. 88, no. 3, p. 273-280 (2008)
Permanent URL
  1. Linet MS, Ries LA, Smith MA et al (1999) Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051–1058
  2. Ransohoff RM, Kivisakk P, Kidd G (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3:569–581
  3. Galea I, Bernardes-Silva M, Forse PA et al (2007) An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J Exp Med 204:2023–2030
  4. Lampson LA (2003) Brain tumor immunotherapy: an immunologist’s perspective. J Neurooncol 64:3–11
  5. Khan-Farooqi HR, Prins RM, Liau LM (2005) Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies. Neurol Res 27:692–702
  6. de Vleeschouwer S, Rapp M, Sorg RV et al (2006) Dendritic cell vaccination in patients with malignant gliomas: current status and future directions. Neurosurgery 59:988–999 discussion 99–1000
  7. Mackall CL, Fleisher TA, Brown MR et al (1995) Age, thymopoiesis, and CD4 + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143–149
  8. Heitger A, Greinix H, Mannhalter C et al (2000) Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation 69:2366–2373
  9. van der Bruggen P, Traversari C, Chomez P et al (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643–1647
  10. Van Der Bruggen P, Zhang Y, Chaux P et al (2002) Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 188:51–64
  11. Jacobs JF, Brasseur F, Hulsbergen-van de Kaa CA et al (2007) Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR. Int J Cancer 120:67–74
  12. Raff T, van der Giet M, Endemann D et al (1997) Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques 23:456–460
  13. Zammatteo N, Lockman L, Brasseur F et al (2002) DNA microarray to monitor the expression of MAGE-A genes. Clin Chem 48:25–34
  14. So T, Hanagiri T, Chapiro J et al (2007) Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules. Cancer Immunol Immunother 56:259–269
  15. Kholmanskikh O, Loriot A, Brasseur F et al (2008) Expression of BORIS in melanoma: lack of association with MAGE-A1 activation. Int J Cancer 122:777–784
  16. Jungbluth AA, Chen YT, Stockert E et al (2001) Immunohistochemical analysis of NY-ESO-1 antigen in normal and malignant human tissues. Int J Cancer 92:856–860
  17. Chen YT, Stockert E, Chen Y et al (1994) Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc Natl Acad Sci USA 91:1004–1008
  18. Kocher T, Schultz-Thater E, Gudat F et al (1995) Identification and intracellular location of MAGE-3 gene product. Cancer Res 55:2236–2239
  19. Landry C, Brasseur F, Spagnoli GC et al (2000) Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer 86:835–841
  20. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 114:97–109
  21. Bodey B, Siegel SE, Kaiser HE (2002) MAGE–1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression. In Vivo 16:583–588
  22. Rimoldi D, Romero P, Carrel S (1993) The human melanoma antigen-encoding gene, MAGE-1, is expressed by other tumour cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 54:527–528
  23. Chi DD, Merchant RE, Rand R et al (1997) Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol 150:2143–2152
  24. Sahin U, Koslowski M, Tureci O et al (2000) Expression of cancer testis genes in human brain tumors. Clin Cancer Res 6:3916–3922
  25. Velders MP, Markiewicz MA, Eiben GL et al (2003) CD4+ T cell matters in tumor immunity. Int Rev Immunol 22:113–140
  26. Kershaw MH, Trapani JA, Smyth MJ (1995) Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer. Ther Immunol 2:173–181
  27. Boon T, Cerottini JC, Van den Eynde B et al (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337–365
  28. Rosenberg SA (2001) Progress in human tumour immunology and immunotherapy. Nature 411:380–384
  29. Kalos M (2003) Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects. Vaccine 21:781–786
  30. Sinkovics JG, Horvath JC (2000) Vaccination against human cancers (review). Int J Oncol 16:81–96
  31. Bodey B, Bodey B Jr, Siegel SE (1995) Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors. Mod Pathol 8:333–338
  32. Simpson AJ, Caballero OL, Jungbluth A et al (2005) Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5:615–625
  33. Litofsky NS, Hinton D, Raffel C (1994) The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery 34:967–972 discussion 72–73
  34. Sure U, Ruedi D, Tachibana O et al (1997) Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol 56:782–789
  35. Rickert Christian H., Sträter Ronald, Kaatsch Peter, Wassmann Hansdetlef, Jürgens Heribert, Dockhorn-Dworniczak Barbara, Paulus Werner, Pediatric High-Grade Astrocytomas Show Chromosomal Imbalances Distinct from Adult Cases, 10.1016/s0002-9440(10)64103-x
  36. Szybka M, Bartkowiak J, Zakrzewski K et al (2003) Microsatellite instability and expression of DNA mismatch repair genes in malignant astrocytic tumors from adult and pediatric patients. Clin Neuropathol 22:180–186